Current status and future perspectives of liquid biopsy in non-small cell lung cancer

With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling and analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sunhee, Hur, Jae Young, Choi, Yoon-La, Lee, Chang Hun, Kim, Wan Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253954/
https://www.ncbi.nlm.nih.gov/pubmed/32460474
http://dx.doi.org/10.4132/jptm.2020.02.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253954/
https://www.ncbi.nlm.nih.gov/pubmed/32460474
http://dx.doi.org/10.4132/jptm.2020.02.27

Ejemplares similares